What insurance policy changes affect CPT 52450?

There are 9 tracked policy changes affecting CPT 52450, including updates from Aetna, Independence Blue Cross. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for CPT 52450?

Payers that have issued tracked updates for CPT 52450 include: Aetna, Independence Blue Cross.

How do I get notified when CPT 52450 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to CPT 52450. You will receive a daily digest email whenever a new policy change references this code.

Why do payers change policies for CPT 52450?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

52450 — A procedure where the doctor uses a camera to go through the urethra and remove or reduce prostate tissue causing blockage.: Insurance Policy Changes

52450 Insurance Policy Changes

CPT 52450, in plain terms, covers A procedure where the doctor uses a camera to go through the urethra and remove or reduce prostate tissue causing blockage. CPT 52450 is referenced in 9 tracked payer policy changes from Aetna and Independence Blue Cross. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 52450 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Medium impact

Benign Prostatic Hyperplasia (CPB 0079, reviewed 2026-10-15)

Aetna·Identified Oct 23, 2026

Aetna's Clinical Policy Bulletin 0079 on Benign Prostatic Hyperplasia (CPB 0079) was reviewed on 2026-10-15 and establishes medical necessity criteria for BPH treatments, including covered procedures (alpha-blockers, laser therapies, UroLift, tadalafil, etc.) and experimental/investigational approaches that are not covered. The policy specifies coverage limitations for certain devices (UroLume age/prostate size requirements; iTind for specific prostate volumes) and outlines applicable billing codes. This is a policy review document, not a change announcement with a new effective date.

52450 Insurance Policy Changes

Benign Prostatic Hyperplasia (CPB 0079, reviewed 2026-04-15)

MA11.004q, Surgical and Minimally Invasive Treatments for Urinary Outlet Obstruction due to Benign Prostatic Hyperplasia (BPH)

11.17.06w, Surgical and Minimally Invasive Treatments for Urinary Outlet Obstruction due to Benign Prostatic Hyperplasia (BPH)

11.17.06v, Surgical and Minimally Invasive Treatments for Urinary Outlet Obstruction due to Benign Prostatic Hyperplasia (BPH)

MA11.004r, Surgical and Minimally Invasive Treatments for Urinary Outlet Obstruction due to Benign Prostatic Hyperplasia (BPH)

11.17.06x, Surgical and Minimally Invasive Treatments for Urinary Outlet Obstruction due to Benign Prostatic Hyperplasia (BPH)

MA11.004p, Surgical and Minimally Invasive Treatments for Urinary Outlet Obstruction due to Benign Prostatic Hyperplasia (BPH)

11.17.06u, Surgical and Minimally Invasive Treatments for Urinary Outlet Obstruction due to Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia (CPB 0079, reviewed 2026-10-15)